3 Top Growth Stocks to Buy on the Dip
All of these stocks are down more than 10% in the past four weeks.
Seagen Inc.
SGEN
SGEN
$182.75
-$3.03
-1.6%
Price as of January 22, 2021, 9:00 p.m. EST
View Interactive SGEN Charts
A biotechnology company that develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
Interactive Chart
News & Analysis: Seagen Inc.
The Fool has written over 200 articles on Seagen Inc..
Why Seagen Shares Are Tumbling 12.5% Today
A broad market sell-off is trumping third-quarter results that outpaced analyst expectations.
Seattle Genetics (SGEN) Q3 2020 Earnings Call Transcript
SGEN earnings call for the period ending September 30, 2020.
Why Seattle Genetics Stock Jumped 24% in September
Investors celebrated news of a big partnership -- and a big capital infusion.
Next Coronavirus Market Crash: Where to Invest $10,000
Prep your portfolio by buying shares of healthcare companies that can deliver revenue growth in the worst of times.
Merck Inks Multibillion-Dollar Deal With Seattle Genetics, Including Equity
Merck is acquiring $1 billion in Seattle Genetics shares as part of a wide-ranging collaboration agreement.
Seattle Genetics (SGEN) Q2 2020 Earnings Call Transcript
SGEN earnings call for the period ending June 30, 2020.
Why Seattle Genetics Shares Climbed 48.7% in the First Half
Two drug approvals in just a few months gave investors reason to cheer.
3 Biotech Stocks I’d Buy Right Now
These companies have products, products, and more products to keep revenue flowing.
Seattle Genetics Inc (SGEN) Q1 2020 Earnings Call Transcript
SGEN earnings call for the period ending March 31, 2020.
